Back to News

DRUG RECALL ALERT - Recall of Chantix by Pfizer

September 22, 2021

Pfizer announced a voluntary consumer-level recall of all lots of Chantix (varenicline) tablets due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable daily intake limit.

Clinical Services will be conducting a drug recall mailing to potentially impacted members and providers. Below are mailing details.

Product

Manufacturer

Recall identification date

Affected NDCs

Look back period

Target population for clinical mailing

Messaging type

Data release

Fulfillment due date for NCQA compliance

Chantix (varenicline)

Pfizer

9/17/2021

0069-0468-56; 0069-0469-56; 0069-0469-03; 0069-0471-03

5/19/2021 – 9/17/2021

All

Mailing: Members; Direct Message/Fax: Providers

SS00005114

On or before: 10/07/21